Investment and M&A transaction comps
CPG Investment & M&A Transaction Comps
Global CPG and consumer brand investments, capital raises and M&A transactions, including food, beverage, beauty, personal care, supplements and adjacent branded consumer categories.
213
Reviewed transactions
149
With price data
4.1x
Median EV or valuation / revenue
16.3x
Median EV or valuation / EBITDA
| Year | Transactions | Priced | Median EV or valuation / revenue | Median EV or valuation / EBITDA |
|---|---|---|---|---|
| 2026 | 12 | 9 | 4.0x | 9.9x |
| 2025 | 14 | 14 | 3.3x | 12.7x |
| 2024 | 12 | 11 | 3.6x | 16.0x |
| 2023 | 20 | 18 | 4.0x | 20.9x |
| 2022 | 20 | 10 | 4.9x | 20.4x |
| 2021 | 25 | 20 | 4.7x | 15.2x |
| 2020 | 15 | 10 | 4.2x | 14.7x |
| 2019 | 8 | 7 | 4.3x | 17.4x |
Sortable transaction comps
CPG transaction table
Rows with reported value
23 / 25
Acquisition EV, USD
USD 20B
Investment EV, USD
USD 7.2B
Median EV / revenue
3.8x
Select up to 12 rows across filters and pages, then share or export the set.
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
25 shown of 213 matching transactions. Click any transaction row for more detail.
Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Alani Nu Control | 2025-02-20 | Celsius Holdings | USD 1.6B Net Purchase Price | 1,650 | 2.8x | 12.0x | United States | Confirmed 3 sources | ||
| Minimalist Control (91%) | 2025-01-22 | Hindustan Unilever | INR 30B Pre Money Enterprise Value | 342 | 5.9x | - | India | Confirmed 3 sources | ||
| Sour Strips Control | 2024-11-08 | The Hershey Company | Undisclosed | Undisclosed | - | - | United States | Confirmed 3 sources | ||
| Vuori Minority | 2024-11-08 | General Atlantic and Stripes | USD 5.5B Enterprise Value | 5,500 | 5.5x | - | United States | Confirmed 6 sources | ||
| Supreme Control | 2024-07-17 | EssilorLuxottica S.A. | USD 1.5B Enterprise Value | 1,500 | 2.8x | - | United States | Confirmed 5 sources | ||
| Graphico, Inc. Control | 2024-06-03 | Church & Dwight Co., Inc. | USD 21.9M Enterprise Value | 22 | 0.6x | - | Japan | Estimated 38 sources | ||
| Beautynova Control | 2024-03-18 | PAI Partners | EUR 330M Enterprise Value | 365 | 2.5x | 10.6x | Italy | Estimated 1 source | ||
| 2024-03-12 | Campbell's | USD 2.9B Enterprise Value | 2,899 | - | - | United States | Confirmed 26 sources | |||
| Liquid Death Capital Raise | 2024-03-11 | Live Nation and other investors | USD 1.4B Enterprise Value | 1,400 | 4.2x | - | United States | Confirmed 4 sources | ||
| ChapStick Control | 2024-01-25 | Suave Brands Company | USD 510M Consideration | 510 | 3.6x | - | Global | Estimated 2 sources | ||
| Ultra Violette Capital Raise | 2024-01-23 | Aria Growth Partners | AUD 15.0M Investment Amount | 10 | - | - | Australia | Confirmed 1 source | ||
| RoC Skincare Control | 2024-01-23 | Bridgepoint | EUR 462M Enterprise Value | 511 | 3.3x | 20.0x | - | Estimated 1 source | ||
| Sunday Natural Control (55%) | 2024-01-15 | CVC Capital Partners | EUR 800M Enterprise Value | 875 | 8.0x | 16.0x | Germany | Estimated 1 source | ||
| Dr. Barbara Sturm Control | 2024-01-01 | Puig | EUR 320M Enterprise Value | 354 | 5.0x | - | - | Estimated 2 sources | ||
| La Colombe Coffee Roasters Control | 2023-12-15 | Chobani | USD 900M Enterprise Value | 900 | - | - | United States | Confirmed 1 source | ||
| Go-To Skincare Control (50%) | 2023-12-15 | Zoë Foster Blake | AUD 43.5M Enterprise Value | 29 | - | - | Australia | Confirmed 2 sources | ||
| Straand Capital Raise | 2023-12-10 | Unilever Ventures | USD 4.0M Investment Amount | 4 | - | - | Australia | Confirmed 1 source | ||
| Lactobio Control | 2023-12-04 | L’Oréal | Undisclosed Undisclosed | Undisclosed | - | - | Denmark | Confirmed 1 source | ||
| Bonafide Health Control | 2023-11-30 | Pharmavite | USD 425M Consideration | 425 | - | - | - | Confirmed 1 source | ||
| COSRX Control (38%) | 2023-10-30 | Amorepacific | USD 1.0B Enterprise Value | 1,000 | 3.6x | - | South Korea | Confirmed 2 sources | ||
| Viatris OTC business Control | 2023-10-01 | Cooper Consumer Health | EUR 1.9B Consideration | 2,066 | - | - | Europe | Confirmed 2 sources | ||
| Hostess Brands, Inc. Control (100%) | 2023-09-11 | The J. M. Smucker Company | USD 5.6B Enterprise Value | 5,600 | 3.9x | 17.2x | United States | Confirmed 3 sources | ||
| La Rosée Minority (20%) | 2023-09-09 | FG Bros | EUR 250M Enterprise Value | 268 | 4.5x | 14.2x | - | Confirmed 1 source | ||
| Naturium Control | 2023-08-29 | Elf | EUR 328M Enterprise Value | 354 | 3.9x | 20.9x | US (California) | Estimated 1 source | ||
| Thorne HealthTech Control | 2023-08-28 | L Catterton | USD 681M Enterprise Value | 681 | 3.7x | 21.2x | - | Estimated 2 sources |
FundComb transaction comps are informational only. Prices are shown as estimated enterprise value where available, with USD used as the default sorting currency; revenue and EBITDA multiples are shown where available. Values may be estimated, rumored, incomplete or derived from public information and should not be relied upon as financial, investment or valuation advice.